iBio reports fiscal Q1 2027 results, advances IBIO-600 and IBIO-610 programsNov 10Clinical readoutiBio, Inc.PMGC Holdings Inc.Updated
PMGC's NorthStrive and Yuva Biosciences expand AI drug discovery pactSep 2PartnershipPMGC Holdings Inc.
PMGC subsidiary NorthStrive Defense Tech secures exclusive license tied to aerospace patentJul 9M&APMGC Holdings Inc.
PMGC subsidiary reports positive Phase III results from AI drug discovery work with Yuva BiosciencesJul 1Clinical readoutPMGC Holdings Inc.